The Regulatory Effects of Citrus Peel Powder on Liver Metabolites and Gut Flora in Mice with Non-Alcoholic Fatty Liver Disease (NAFLD)

被引:47
作者
Hu, Meiyi [1 ,2 ,3 ]
Zhang, Li [2 ,3 ]
Ruan, Zheng [1 ,2 ,3 ]
Han, Peiheng [2 ,3 ]
Yu, Yujuan [2 ,3 ]
机构
[1] Beijing Technol & Business Univ BTBU, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing 100048, Peoples R China
[2] Nanchang Univ, Inst Nutr, State Key Lab Food Sci & Technol, Nanchang 330047, Jiangxi, Peoples R China
[3] Nanchang Univ, Sch Food Sci, Nanchang 330047, Jiangxi, Peoples R China
关键词
citrus peel; liver metabolites; gut flora; non-alcoholic fatty liver disease; pomelo; orange; FECAL MICROBIOTA; OBESITY; PECTINS;
D O I
10.3390/foods10123022
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Gannan navel orange and Jinggang pomelo, belonging to the genus Citrus, are good sources of phenolic compounds, which are mainly concentrated in the peel. These phenolic compounds are considered promising in the prevention and treatment of non-alcoholic fatty liver disease (NAFLD). In order to maximize nutrients retention and bioactivity in the peel, pomelo peel and orange peel were processed using freeze-drying technology and mixed in the ratio (pomelo peel powder 50% and orange peel powder 50%) to make citrus peel powder (CPP). The purpose of this study was to explore new strategies and mechanisms associated with the consumption of CPP to alleviate nonalcoholic fatty liver injury, lipid metabolism disorders, and gut microbiota dysbiosis in obese mice induced by high-fat diet (HFD). The results showed that after 12 weeks of CPP administration, CPP supplementation had a strong inhibitory effect on HFD-induced weight gain, hepatic fat accumulation, dyslipidemia, and the release of pro-inflammatory cytokines. In particular, CPP modulates the composition of the intestinal flora, such as increasing the relative abundance of phylum Firmicutes, genus Faecalibaculum, genus Lactobacillus, genus Dubosiella, and genus Lachnospiraceae_NK4A136_ group and decreasing the relative abundance of phylum Bacteroidota, genus Helicobacter, and genus Bacteroides. These results suggest that CPP has a preventive effect on NAFLD, which can be related to the regulation of intestinal flora.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)
    Kanuri, Giridhar
    Bergheim, Ina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (06): : 11963 - 11980
  • [32] The Gut Microbiota and Its Metabolites, Novel Targets for Treating and Preventing Non-Alcoholic Fatty Liver Disease
    Ni, Yinhua
    Ni, Liyang
    Zhuge, Fen
    Fu, Zhengwei
    MOLECULAR NUTRITION & FOOD RESEARCH, 2020, 64 (17)
  • [33] Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Concepts
    Papatheodoridi, Margarita
    Cholongitas, Evangelos
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (38) : 4574 - 4586
  • [34] Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD)
    Saeed, Ali
    Dullaart, Robin P. F.
    Schreuder, Tim C. M. A.
    Blokzijl, Hans
    Faber, Klaas Nico
    NUTRIENTS, 2018, 10 (01)
  • [35] Immunology of gut microbiome and liver in non-alcoholic fatty liver disease (NAFLD): mechanisms, bacteria, and novel therapeutic targets
    Stanislav Konstantinovich Gruzdev
    Irina Viktorovna Podoprigora
    Oksana Anatolievna Gizinger
    Archives of Microbiology, 2024, 206
  • [36] Non-alcoholic fatty liver disease (NAFLD) - epidemic of the XXI century
    Maciejewska, Dominika
    Stachowska, Ewa
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2018, 72 : 659 - 670
  • [37] Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) in the Paediatric Population
    D'Adamo, Ebe
    Chiarelli, Francesco
    Mohn, Angelika
    RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY, 2009, 3 (02) : 94 - 101
  • [38] Gut-liver axis, nutrition, and non-alcoholic fatty liver disease
    Kirpich, Irina A.
    Marsano, Luis S.
    McClain, Craig J.
    CLINICAL BIOCHEMISTRY, 2015, 48 (13-14) : 923 - 930
  • [39] Immunology of gut microbiome and liver in non-alcoholic fatty liver disease (NAFLD): mechanisms, bacteria, and novel therapeutic targets
    Gruzdev, Stanislav Konstantinovich
    Podoprigora, Irina Viktorovna
    Gizinger, Oksana Anatolievna
    ARCHIVES OF MICROBIOLOGY, 2024, 206 (02)
  • [40] Lean non-alcoholic fatty liver disease (Lean-NAFLD): a major cause of cryptogenic liver disease
    Vos, Bertrand
    Moreno, Christophe
    Nagy, Nathalie
    Fery, Francoise
    Cnop, Miriam
    Vereerstraeten, Pierre
    Deviere, Jacques
    Adler, Michael
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2011, 74 (03): : 389 - 394